Visceral adipose tissue and body fat mass: Predictive values for and role of gender in cardiometabolic risk among Turks
Received 16 February 2009; accepted 18 May 2009. published online 27 July 2009.
Abstract
Objective
We investigated the predictive values of visceral adipose tissue area (VAT) and body fat mass for a composite endpoint consisting of type 2 diabetes and coronary heart disease and for incident metabolic syndrome.
Methods
We analyzed at 4-y follow-up 157 middle-aged men and women in whom body composition analyzer and single-scan computerized tomography had been used.
Results
Sex- and age-adjusted mean areas of visceral fat were 1.5-fold greater in individuals with than without the composite endpoint (P<0.001), whereas abdominal subcutaneous fat was similar. Analysis of receiver operating characteristics for the optimal criterion regarding the composite endpoint (in 37 participants) indicated a VAT of 130cm2 and accuracies of 60% in men and 85% in women. Whereas age-adjusted VAT alone significantly predicted the composite endpoint in men, body fat mass or VAT predicted it in women (with 2.2- to 2.6-fold relative risks for 1-SD increment). Age-adjusted incident metabolic syndrome was significantly predicted by each parameter in men but only by fat mass in women.
Conclusion
Visceral adiposity in men and body fat mass in women seem to be of greater relevance in cardiometabolic risk for the prediction of which 130cm2 of VAT in both sexes and/or 27kg of fat mass in women are useful cutoffs. Sex differences may reflect the predominating role of visceral adiposity in men and of insulin resistance in women in this risk.
The Turkish Adult Risk Factor survey 2006–2008 was supported by the Turkish Society of Cardiology and the pharmaceutical companies SanofiAventis, Pfizer, Novartis, and AstraZeneca, Istanbul, Turkey.
ABSTRACT